MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,681 Cr | ₹2,190 Cr | ₹1,660 Cr | ₹1,228 Cr | ₹902 Cr |
What is the latest Total Liabilities ratio of MARKSANS PHARMA ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,681 Cr |
Mar2023 | ₹2,190 Cr |
Mar2022 | ₹1,660 Cr |
Mar2021 | ₹1,228 Cr |
Mar2020 | ₹902 Cr |
How is Total Liabilities of MARKSANS PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,681 Cr | 22.40 | |
Mar2023 | ₹2,190 Cr | 31.94 | |
Mar2022 | ₹1,660 Cr | 35.19 | |
Mar2021 | ₹1,228 Cr | 36.14 | |
Mar2020 | ₹902 Cr | - |
Compare Total Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹13,485.0 Cr | 3.6% | -13.8% | 85.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 3.6% |
-13.8% |
85.3% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses